Mitsubishi UFJ Morgan Stanley Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,120
Closed -$211K 151
2022
Q4
$211K Buy
4,120
+2,190
+113% +$105K 1.85% 6
2022
Q3
$84K Hold
1,930
1.13% 14
2022
Q2
$101K Hold
1,930
0.14% 13
2022
Q1
$100K Sell
1,930
-2,070
-52% -$107K 0.09% 12
2021
Q4
$236K Sell
4,000
-290
-7% -$14.4K 0.12% 18
2021
Q3
$185K Buy
4,290
+1,560
+57% +$69.1K 0.17% 16
2021
Q2
$107K Buy
+2,730
New +$106K 0.8% 22
2014
Q4
$45K Hold
1,528
0.09% 58
2014
Q3
$43K Buy
1,528
+305
+25% +$8.56K 0.12% 66
2014
Q2
$34K Sell
1,223
-1,412
-54% -$40.3K 0.1% 75
2014
Q1
$80K Sell
2,635
-527
-17% -$15.7K 0.21% 33
2013
Q4
$92K Buy
3,162
+1,033
+49% +$30.1K 0.15% 26
2013
Q3
$58K Buy
2,129
+1,180
+124% +$32.1K 0.1% 50
2013
Q2
$25K Buy
+949
New +$26.2K 0.08% 130

Other funds holding PFE

Mitsubishi UFJ Morgan Stanley Securities's PFE Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,120 shares — an estimated $211K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $236K in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 4,120 Pfizer shares in Q1 2023, an estimated $211K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Pfizer position peaked at $236K in Q4 2021.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.